103 related articles for article (PubMed ID: 25843800)
21. FoxO3a and nilotinib-induced erythroid differentiation of CML-BC cells.
Wang W; Li NN; Du Y; Lv FF; Lin GQ
Leuk Res; 2013 Oct; 37(10):1309-14. PubMed ID: 23915976
[TBL] [Abstract][Full Text] [Related]
22. MiR-155 is upregulated in patients with active tuberculosis and inhibits apoptosis of monocytes by targeting FOXO3.
Huang J; Jiao J; Xu W; Zhao H; Zhang C; Shi Y; Xiao Z
Mol Med Rep; 2015 Nov; 12(5):7102-8. PubMed ID: 26324048
[TBL] [Abstract][Full Text] [Related]
23. Following Transcriptome to Uncover FOXO Biological Functions.
Liang R; Menon V; Ghaffari S
Methods Mol Biol; 2019; 1890():219-227. PubMed ID: 30414157
[TBL] [Abstract][Full Text] [Related]
24. Advances in understanding the mechanisms of erythropoiesis in homeostasis and disease.
Liang R; Ghaffari S
Br J Haematol; 2016 Sep; 174(5):661-73. PubMed ID: 27442953
[TBL] [Abstract][Full Text] [Related]
25. RNA interference-mediated silencing of Foxo3 in antigen-presenting cells as a strategy for the enhancement of DNA vaccine potency.
Wang ST; Chang CC; Yen MC; Tu CF; Chu CL; Peng YT; Chen DY; Lan JL; Lin CC
Gene Ther; 2011 Apr; 18(4):372-83. PubMed ID: 21107437
[TBL] [Abstract][Full Text] [Related]
26. Different roles of Foxo1 and Foxo3 in the control of endothelial cell morphology.
Matsukawa M; Sakamoto H; Kawasuji M; Furuyama T; Ogawa M
Genes Cells; 2009 Oct; 14(10):1167-81. PubMed ID: 19747349
[TBL] [Abstract][Full Text] [Related]
27. miR-451 protects against erythroid oxidant stress by repressing 14-3-3zeta.
Yu D; dos Santos CO; Zhao G; Jiang J; Amigo JD; Khandros E; Dore LC; Yao Y; D'Souza J; Zhang Z; Ghaffari S; Choi J; Friend S; Tong W; Orange JS; Paw BH; Weiss MJ
Genes Dev; 2010 Aug; 24(15):1620-33. PubMed ID: 20679398
[TBL] [Abstract][Full Text] [Related]
28. The role of FOXO3 in DNA damage response in thyrocytes.
Klagge A; Weidinger C; Krause K; Jessnitzer B; Gutknecht M; Fuhrer D
Endocr Relat Cancer; 2011 Oct; 18(5):555-64. PubMed ID: 21712344
[TBL] [Abstract][Full Text] [Related]
29. A novel function of FoxO transcription factors in thrombin-stimulated vascular smooth muscle cell proliferation.
Mahajan SG; Fender AC; Meyer-Kirchrath J; Kurt M; Barth M; Sagban TA; Fischer JW; Schrör K; Hohlfeld T; Rauch BH
Thromb Haemost; 2012 Jul; 108(1):148-58. PubMed ID: 22552808
[TBL] [Abstract][Full Text] [Related]
30. Activation of FKHRL1 plays an important role in protecting erythroid cells from erythropoietin deprivation-induced apoptosis in a human erythropoietin-dependent leukemia cell line, UT-7/EPO.
Uchida M; Kirito K; Endo H; Ozawa K; Komatsu N
Int J Hematol; 2007 Nov; 86(4):315-24. PubMed ID: 18055337
[TBL] [Abstract][Full Text] [Related]
31. Generation of Foxo3-targeted Mice by Injection of mRNAs Encoding Transcription Activator-like Effector Nucleases (TALENs) into Zygotes.
Zhu P; Liu Q; Liu S; Su X; Feng W; Lei X; Liu J; Cui K; Huang B; Shi D
Reprod Domest Anim; 2015 Jun; 50(3):474-83. PubMed ID: 25800339
[TBL] [Abstract][Full Text] [Related]
32. Insulin-FOXO3 signaling modulates circadian rhythms via regulation of clock transcription.
Chaves I; van der Horst GT; Schellevis R; Nijman RM; Koerkamp MG; Holstege FC; Smidt MP; Hoekman MF
Curr Biol; 2014 Jun; 24(11):1248-55. PubMed ID: 24856209
[TBL] [Abstract][Full Text] [Related]
33. Molecular cloning, characterisation and functional analysis of the duck Forkhead box O3 (FOXO3) gene.
Gan W; He H; Li L
Br Poult Sci; 2016 Apr; 57(2):143-50. PubMed ID: 26751098
[TBL] [Abstract][Full Text] [Related]
34. Investigation of FoxO3 dynamics during erythroblast development in β-thalassemia major.
Thanuthanakhun N; Nuntakarn L; Sampattavanich S; Anurathapan U; Phuphanitcharoenkun S; Pornpaiboonstid S; Borwornpinyo S; Hongeng S
PLoS One; 2017; 12(11):e0187610. PubMed ID: 29099866
[TBL] [Abstract][Full Text] [Related]
35. Lineage-specific growth inhibition of NK cell lines by FOXO3 in association with Akt activation status.
Karube K; Tsuzuki S; Yoshida N; Arita K; Liu F; Kondo E; Ko YH; Ohshima K; Nakamura S; Kinoshita T; Seto M
Exp Hematol; 2012 Dec; 40(12):1005-1015.e6. PubMed ID: 22922206
[TBL] [Abstract][Full Text] [Related]
36. Activation of the Akt/FKHRL1 pathway mediates the antiapoptotic effects of erythropoietin in primary human erythroid progenitors.
Uddin S; Kottegoda S; Stigger D; Platanias LC; Wickrema A
Biochem Biophys Res Commun; 2000 Aug; 275(1):16-9. PubMed ID: 10944433
[TBL] [Abstract][Full Text] [Related]
37. FOXO3 selectively amplifies enhancer activity to establish target gene regulation.
Eijkelenboom A; Mokry M; Smits LM; Nieuwenhuis EE; Burgering BM
Cell Rep; 2013 Dec; 5(6):1664-78. PubMed ID: 24360957
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of FOXO3 tumor suppressor function by betaTrCP1 through ubiquitin-mediated degradation in a tumor mouse model.
Tsai WB; Chung YM; Zou Y; Park SH; Xu Z; Nakayama K; Lin SH; Hu MC
PLoS One; 2010 Jul; 5(7):e11171. PubMed ID: 20625400
[TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation.
Buck I; Morceau F; Cristofanon S; Heintz C; Chateauvieux S; Reuter S; Dicato M; Diederich M
Biochem Pharmacol; 2008 Nov; 76(10):1229-39. PubMed ID: 18805401
[TBL] [Abstract][Full Text] [Related]
40. EDAG positively regulates erythroid differentiation and modifies GATA1 acetylation through recruiting p300.
Zheng WW; Dong XM; Yin RH; Xu FF; Ning HM; Zhang MJ; Xu CW; Yang Y; Ding YL; Wang ZD; Zhao WB; Tang LJ; Chen H; Wang XH; Zhan YQ; Yu M; Ge CH; Li CY; Yang XM
Stem Cells; 2014 Aug; 32(8):2278-89. PubMed ID: 24740910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
